MA71235A - N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoéthyl)- quinoléine-4-carboxamidess - Google Patents

N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoéthyl)- quinoléine-4-carboxamidess

Info

Publication number
MA71235A
MA71235A MA71235A MA71235A MA71235A MA 71235 A MA71235 A MA 71235A MA 71235 A MA71235 A MA 71235A MA 71235 A MA71235 A MA 71235A MA 71235 A MA71235 A MA 71235A
Authority
MA
Morocco
Prior art keywords
carboxamidess
quinoleine
hexan
oxoethyl
azabicyclo
Prior art date
Application number
MA71235A
Other languages
English (en)
Inventor
Jonas BRÅNALT
Maria JOHANSSON
Anneli NORDQVIST
Marianne Swanson
Gavin O'mahony
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MA71235A publication Critical patent/MA71235A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA71235A 2022-06-21 2023-06-20 N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoéthyl)- quinoléine-4-carboxamidess MA71235A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263366700P 2022-06-21 2022-06-21
EP23734211.8A EP4543869A1 (fr) 2022-06-21 2023-06-20 N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoéthyl)- quinoléine-4-carboxamidess
PCT/EP2023/066560 WO2023247488A1 (fr) 2022-06-21 2023-06-20 N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoéthyl)- quinoléine-4-carboxamidess

Publications (1)

Publication Number Publication Date
MA71235A true MA71235A (fr) 2025-04-30

Family

ID=87047759

Family Applications (1)

Application Number Title Priority Date Filing Date
MA71235A MA71235A (fr) 2022-06-21 2023-06-20 N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoéthyl)- quinoléine-4-carboxamidess

Country Status (19)

Country Link
US (1) US20230406840A1 (fr)
EP (1) EP4543869A1 (fr)
JP (1) JP2025525345A (fr)
KR (1) KR20250044660A (fr)
CN (1) CN119562947A (fr)
AR (1) AR129669A1 (fr)
AU (1) AU2023288735A1 (fr)
CA (1) CA3260241A1 (fr)
CL (1) CL2024003889A1 (fr)
CO (1) CO2025000307A2 (fr)
CR (1) CR20250020A (fr)
DO (1) DOP2024000266A (fr)
IL (1) IL317723A (fr)
MA (1) MA71235A (fr)
MX (1) MX2024015642A (fr)
PE (1) PE20251704A1 (fr)
TW (1) TW202417422A (fr)
UY (1) UY40322A (fr)
WO (1) WO2023247488A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1760076A1 (fr) * 2005-09-02 2007-03-07 Ferring B.V. Inhibiteur de FAP
WO2007029086A2 (fr) 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Derives de 3-azabicyclo[3.1.0]hexane en tant qu'inhibiteurs de la dipeptidyl peptidase-iv
US11504364B2 (en) * 2018-12-21 2022-11-22 Praxis Biotech LLC Inhibitors of fibroblast activation protein

Also Published As

Publication number Publication date
EP4543869A1 (fr) 2025-04-30
CR20250020A (es) 2025-05-26
WO2023247488A1 (fr) 2023-12-28
JP2025525345A (ja) 2025-08-05
PE20251704A1 (es) 2025-07-02
UY40322A (es) 2023-12-15
AU2023288735A1 (en) 2025-02-13
MX2024015642A (es) 2025-02-10
US20230406840A1 (en) 2023-12-21
CO2025000307A2 (es) 2025-01-23
IL317723A (en) 2025-02-01
DOP2024000266A (es) 2025-07-15
CL2024003889A1 (es) 2025-02-07
KR20250044660A (ko) 2025-04-01
TW202417422A (zh) 2024-05-01
CN119562947A (zh) 2025-03-04
AR129669A1 (es) 2024-09-18
CA3260241A1 (fr) 2023-12-28

Similar Documents

Publication Publication Date Title
EP4267598A4 (fr) Nouvelles protéines inhibitrices d'insectes
EP4116039A4 (fr) Machine d'entraînement
EP3914608A4 (fr) Nouvelles protéines d'inhibition des insectes
EP4217352A4 (fr) Analogues de n-(2-(2,6-dioxopipéridine-3-yl)-1,3-dioxoisoindoline-5-yl)arylsulfonamide substitués en tant que modulateurs de la protéine cereblon
EP3915731A4 (fr) Machine d'entraînement
EP4121556A4 (fr) Détection d'analyte
EP3885377A4 (fr) Polymère à base d'oléfine
AU2021403827A1 (en) N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- quinoline-4-carboxamides
MA71235A (fr) N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoéthyl)- quinoléine-4-carboxamidess
MA55010A (fr) Système d'électrodes
MA56386A (fr) Polythérapie comprenant de l'acétyl-leucine et du miglustat
EP4114428A4 (fr) Polypeptides d'ulinastatine
HK40125947A (en) N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides
EP4412531A4 (fr) Adaptation de rapport de nodules
EP4506473A4 (fr) Matériau en acier
EP4215199A4 (fr) Activateur d'autophagie
EP4085954A4 (fr) Machine d'anesthésie
MA71225A (fr) Neuropeptides d'insectes
MA71226A (fr) Neuropeptides d'insectes
MA71223A (fr) Neuropeptides d'insectes
MA71224A (fr) Neuropeptides d'insectes
MA71228A (fr) Neuropeptides d'insectes
MA71227A (fr) Neuropeptides d'insectes
UA46138S (uk) 1. кронштейн
UA46392S (uk) 1. нічник